Detalhe da pesquisa
1.
Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile.
Front Public Health
; 11: 1229045, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693706
2.
Surface Immunogenic Protein of Streptococcus Group B is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune Adjuvant.
Vaccines (Basel)
; 8(1)2020 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31963234